Certain genetic variations can be associated with an increased risk for inherited conditions.

Identifying those variations may help physicians better understand a patient’s risk profile and determine whether additional evaluation, monitoring, counseling, or other clinical steps should be considered.

People can differ biologically in ways that affect disease risk and response to treatment.

Genomic information may provide physicians with additional information that helps them consider care decisions in the context of the individual patient rather than relying only on a general population approach.

Pharmacogenomics looks at how genetic differences may affect a person’s response to certain medications.

This information may help physicians consider medication selection or management together with the patient’s health history, other medications, and clinical circumstances.

Family history can provide clues about conditions that may have an inherited component.

When several family members have the same or related conditions, or when disease occurs unusually early, a physician may consider whether genetic evaluation could provide additional useful information.

Genomic testing can have applications in areas such as oncology, cardiology, reproductive health, rare disease, pharmacogenomics, and other areas of clinical care.

The type of testing and its clinical relevance depend on the patient’s situation and the physician’s clinical judgment.

Once a physician determines that testing is appropriate, the administrative and logistical steps required to move the case forward can begin.

These may include eligibility review, required documentation, authorization activities, laboratory coordination, sample logistics, case tracking, and results delivery.

Testing is performed through qualified reference laboratory partners.

MediniPathway™ is designed to help coordinate the operational steps between the physician, patient, laboratory, and other participating healthcare stakeholders.

The laboratory generates the test report, and results are made available through the appropriate clinical workflow.

The ordering physician or another qualified healthcare professional reviews the results in the context of the patient’s overall clinical picture.

MediniPathway™ supports the administrative and coordination activities surrounding physician-directed genomic testing.

Its role is to help connect the steps from ordering and authorization through laboratory coordination, results delivery, and appropriate follow-up. Clinical decisions remain with the physician.

MediniPathway™ is designed to support the different stakeholders involved in a genomic testing journey, including physicians, patients, laboratory partners, health systems, payers, and administrative teams.

Each stakeholder interacts with the process according to their role.

MediniPathway™ is designed to support activities such as case intake, eligibility, prior authorization, laboratory coordination, case tracking, results delivery, and follow-up workflows.

The platform supports the operational process while leaving clinical decisions with the physician.

MediniPathway™ is designed to connect the information and operational steps required between participating physicians, laboratories, healthcare organizations, and other stakeholders.

Testing itself is performed through qualified reference laboratory partners.

No. The physician independently determines whether genomic testing is appropriate and which test should be ordered.

MediniPathway™ supports the administrative and logistical workflow that follows the physician’s clinical decision.

MediniPathway™ is designed to help coordinate the administrative and operational steps that follow a physician’s decision to order genomic testing.

These may include eligibility, documentation, authorization, laboratory coordination, logistics, case tracking, results delivery, and follow-up workflows.

No. Test selection remains at the independent clinical discretion of the ordering physician.

MediniPathway™ supports the coordination process after the clinical decision has been made.

MediniPathway™ is designed to support the exchange of necessary operational information and documentation between physicians and qualified reference laboratory partners.

The reference laboratory performs the testing and generates the laboratory report.

The platform is designed to coordinate activities such as documentation, eligibility review, prior authorization, laboratory routing, case tracking, and other administrative workflows associated with the testing journey.

This allows the physician to remain focused on clinical decision-making while the operational process is coordinated around the case.

Medini works with physicians, health systems, laboratories and payers to coordinate the administrative steps around genomic testing. We are not your healthcare provider, and we do not diagnose or treat conditions.

Your physician. Testing is ordered at your physician’s independent clinical judgment, based on your health history and circumstances. Medini does not recommend or select tests.

Yes. Testing is ordered by your physician, and the steps below begin only after that decision.

We help your physician’s office coordinate the steps that follow: consent and intake, insurance eligibility checks, documentation and prior authorization, laboratory routing, sample shipping, case tracking and results delivery.

Coverage depends on your plan and the specific test. We help verify eligibility and, at your physician’s request, support prior authorization. We cannot guarantee coverage. Your insurer makes the final determination.

A CLIA/CAP-certified reference laboratory performs the test. The laboratory bills your insurer or you directly. Medini does not perform testing or bill for it.

Medini follows HIPAA requirements, with encryption, role-based access and audit logs. See our Privacy & Data Security page for details.